Pure Global

Access HIV Combo V2 - HIV1/HIV2 antigen/antibody IVD, kit, chemiluminescent immunoassay - ARTG 395594

Access comprehensive regulatory information for Access HIV Combo V2 - HIV1/HIV2 antigen/antibody IVD, kit, chemiluminescent immunoassay in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 395594 and sponsored by Bio-Rad Laboratories Pty Ltd, manufactured by Bio-Rad in France. The device registration started on September 07, 2022.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
ARTG 395594
Class III
Access HIV Combo V2 - HIV1/HIV2 antigen/antibody IVD, kit, chemiluminescent immunoassay
ARTG ID: 395594
Good Name: Bio-Rad Laboratories Pty Ltd - Access HIV Combo V2 - HIV1/HIV2 antigen/antibody IVD, kit, chemiluminescent immunoassay
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

Intended use: Semi-quantitative immunoassay for the detection of HIV p24/p26 antigens and antibodies to HIV1/O/2 inhuman serum and plasma using the Access Immunoassay Systems.

Device Classification
Risk Class
Class III
Product Type
IVD
ARTG Category
IVD
Registration Information
ARTG ID
395594
Start Date
September 07, 2022
Effective Date
September 07, 2022
Manufacturer
Country
France
Address
3 Boulevard Raymond Poincare, 92430 MARNES-LA-COQUETTE